# Gas chromatography for analysis and estimation of 13C at natural abundance level in fatty acids produced from Aurantiochytrium limacinum, a sustainable source of polyunsaturated fatty acid

**Authors:** Amina M. Dirir, Kaumeel Chokshi, Abdelmoneim H. Ali, Media Alhanawi, Mohan Rommala, Mayssa Hachem

PMC · DOI: 10.3389/fbioe.2025.1631063 · 2025-07-22

## TL;DR

This study explores the use of Aurantiochytrium limacinum for producing polyunsaturated fatty acids like DHA and analyzes their carbon isotope ratios using gas chromatography.

## Contribution

The study introduces a sustainable microbial platform for DHA production and demonstrates the utility of compound-specific isotope analysis in tracking PUFA metabolism.

## Key findings

- DHA was the most abundant fatty acid at the exponential phase of A. limacinum growth.
- Compound-specific isotope analysis revealed distinct δ13C values for various fatty acids, indicating 13C depletion.
- The study highlights the potential of CSIA in biomedical research, particularly for neurodegenerative diseases involving DHA.

## Abstract

Aurantiochytrium limacinum (A. limacinum) is a promising microbial source of polyunsaturated fatty acids (PUFAs), particularly Docosahexaenoic Acid (DHA, C22:6n-3). In this study, we first optimized the culture conditions of A. limacinum ATCC MYA-1381 (strain SR21). Cell growth was monitored via optical density, cell counts, and glucose concentration. Cells were harvested at exponential and stationary phases, and lipids were extracted using a green method. Fatty Acid Methyl Esters (FAMEs) were prepared and analyzed using Gas Chromatography-Flame Ionisation Detection (GC-FID). At the exponential phase, DHA was the most abundant (65.6% of total fatty acids) followed by palmitic acid (C16:0) at 34.4%. At the stationary phase, Docosapentaenoic acid (DPA, C22:5n-3) and DHA were the most abundant at 45.4% and 33.9%, before respectively. Myristic acid (C14:0), myristoleic acid (C14:1n-9), palmitic acid (C16:0) were present at 4.6%, 6.2% and 9.9%, respectively. Compound-specific isotope analysis (CSIA) using Gas Chromatography-Combustion-Isotope Ratio Mass Spectrometry (GC-C-IRMS) revealed that all FAMEs had negative δ13C values, indicating depletion in 13C. At the exponential phase, δ13C (‰) of C16:0 and DHA were −16.8 ± 0.2 and −18.5‰ ± 0.1‰, respectively. At the stationary phase, δ13C (‰) of C14:0, C14:1n-9, C16:0, C22:5n-3 and DHA were −10.6 ± 1.1, −11.3 ± 0.1, −11.1 ± 0.2, −8.3 ± 0.2 and −10.6‰ ± 0.1‰, respectively. Overall, our findings emphasized the importance of A. limacinum as a viable microbial platform for environmentally friendly production of PUFA such as DHA. Also, the study reinforced the utility of CSIA in tracking PUFA metabolic fate, which has latent applications in biomedical research, particularly in neurodegenerative disease frameworks where DHA plays a vital role. Finally, these results may also contribute to understanding isotopic fractionation patterns and metabolic flux variations across different microalgal growth phases.

## Linked entities

- **Chemicals:** Docosahexaenoic Acid (DHA) (PubChem CID 6442063)
- **Diseases:** neurodegenerative disease (MONDO:0005559)
- **Species:** Aurantiochytrium limacinum (taxon 87102)

## Full-text entities

- **Diseases:** eyes' diseases (MESH:D005128), FA (MESH:C565561), AD (MESH:D000544), Parkinson's (MESH:D010300), neurodegenerative disease (MESH:D019636)
- **Chemicals:** chloroform (MESH:D002725), palmitic acid (MESH:D019308), K2CO3 (MESH:C037593), hydrogen (MESH:D006859), carotenoids (MESH:D002338), TAGs (MESH:D014280), He (MESH:D006371), Lipid (MESH:D008055), ETA (MESH:D001095), Myristic acid (MESH:D019814), Ni (MESH:D009532), DHA (MESH:D004281), Hexane (MESH:D006586), streptomycin (MESH:D013307), GC- (MESH:C057580), CO2 (MESH:D002245), polysaccharides (MESH:D011134), BF3 (MESH:C021274), sterols (MESH:D013261), nitrogen (MESH:D009584), FA (MESH:D005227), Water (MESH:D014867), CuO (MESH:C030973), 13C (MESH:C000615229), H2SO4 (MESH:C033158), Vitamin E (MESH:D014810), kanamycin (MESH:D007612), ethanol (MESH:D000431), glycerol (MESH:D005990), Carbon (MESH:D002244), Pt (MESH:D010984), 12C-glucose (-), methanol (MESH:D000432), NaCl (MESH:D012965), Isooctane (MESH:C045798), Glucose (MESH:D005947), arachidonic acid (MESH:D016718), toluene (MESH:D014050), ampicillin (MESH:D000667), PUFA (MESH:D005231), oxygen (MESH:D010100), myristoleic acid (MESH:C054211), C22:5n-3 (MESH:C026219)
- **Species:** Isochrysis galbana (species) [taxon 37099], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Aurantiochytrium limacinum ATCC MYA-1381 (strain) [taxon 717989], Thraustochytriidae (thraustochytrids, family) [taxon 33674], Crypthecodinium cohnii (species) [taxon 2866], Schizochytrium (genus) [taxon 4772], Aurantiochytrium limacinum (species) [taxon 87102], PX clade (clade) [taxon 569578], Homo sapiens (human, species) [taxon 9606], Nannochloropsis oculata (species) [taxon 43925]
- **Mutations:** C at 25, C at 5, DELTA
- **Cell lines:** SR21 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_S164)

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12322567/full.md

---
Source: https://tomesphere.com/paper/PMC12322567